BIOCHEMICAL MARKERS OF OBESITY IN THE 18-25-YEAR-OLD PATIENTS
https://doi.org/10.15829/1728-8800-2017-5-34-39
Abstract
Aim. To study the dynamics of metabolic syndrome markers: insulin, glucose, uric acid, triglycerides, low and high density lipoproteides; of food addiction (ghrelin-leptin) in both genders, of 18-25-year-old patients with normal and extensive body fat tissue amount.
Material and methods. Totally, 76 persons participated. At first stage, participants underwent survey on their food related behavior and physical activity. For the evaluation of fat tissue amount OMRON BF 506 devices were used, and the analizator of the balance of water-containing body sectors ABC-01 “Medass”. At the concluding stage of the study all participants underwent biochemical and hormonal blood tests.
Results. Excessive amount of body fat by bioimpedance is common in normal body mass index. Nevertheless, the correlation data on leptin, insulin, lipids and uric acid with gender and amount of fat tissue makes it to suspect subclinical metabolism disorder in the presence of minimal excess of fat tissue.
Conclusion. For the on time more effective prevention of obesity and its consequences as type 2 diabetes, arterial hypertension, etc., it is aimful to use the results of body fat tissue amount measurements, but not empirical calculations.
About the Authors
K. A. Matosyan
A.I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD)
Russian Federation
Moscow
Russian Federation
Moscow
A. N. Oranskaya
A.I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD)
Moscow
Moscow
K. G. Gurevich
A.I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD)
Moscow
Moscow
A. M. Mkrtumyan
A.I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD)
Moscow
Moscow
References
1. Haslam DW, James WP. Obesity. Lancet 2005; 366 (9492): 1197-209.
2. Kojima M, Kangawa K. Ghrelin discovery: a decade after. Endocr Dev 2013; 25: 1-4.
3. Kojima M, Hosoda H, Matsuo H, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
4. Dockray GJ. Gastrointestinal hormones and the dialogue between gut and brain. J Physiol 2014; 592 (14): 2927-41.
5. Cohen P, Spiegelman BM. Cell biology of fat storage. Mol Biol Cell 2016; 27 (16): 2523-7.
6. Marion L, Ken K and Dunger DB. Longitudinal study of leptin concentrations during puberty: sex difference and relationship to changes in body composition. J Cin Endocrinol Metabol 1999; 84 (3): 899-905.
7. Sugrue ML, Hollenberg AN, Cone RG, et al. Regulation of Thyrotropin-Releasing Hormone-Expressing Neurons in Paraventricular Nucleus of the Hypothalamus by Signals of Adiposity. Mol Endocrinol 2010; 24 (12): 2366-81.
8. Bernadette B. Thyroid and Obesity: An Intriguing Relationship. J Clin Endocrinol Metab 2010; 95 (8): 3614-7.
9. Shire A, Gumaa K, Giha HA, et al. Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects. Endocrinol Metab (Seoul) 2017; 32 (2): 230-40.
10. Krauss H, Piątek M, Piątek J, et al. Fasting and postprandial levels of ghrelin, leptin and insulin in lean, obese and anorexic subjects. Prz Gastroenterol 2013; 8 (6): 383-9.
11. Flier JS, Maratos-Flier E. Leptin’s Physiologic Role: Does the Emperor of Energy Balance Have No Clothes? Cell Metab 2017; 26 (1): 24-6.
12. Bjorbaek C. Central leptin receptor action and resistance in obesity. J Investig Med 2009; 57 (7): 789-94.
13. Hamnvik O-P, Koniaris A, Kim SY, et al. Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 2011; 301 (4): E567-84.
Review
For citations:
Matosyan K.A., Oranskaya A.N., Gurevich K.G., Mkrtumyan A.M. BIOCHEMICAL MARKERS OF OBESITY IN THE 18-25-YEAR-OLD PATIENTS. Cardiovascular Therapy and Prevention. 2017;16(5):34-39. (In Russ.) https://doi.org/10.15829/1728-8800-2017-5-34-39
Views:
1214
Email this article 
